Evidence map›Paper›PMID 27165797›Full record

ArticlemBio2016

The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.

Barbara A Fox, Leah M Rommereim, Rebekah B Guevara, Alejandra Falla, Miryam Andrea Hortua Triana, Yanbo Sun, David J Bzik

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Cysteine-S-nitrosylation inhibits Rop5-mediated immune evasion inbioRxiv : the preprint server for biology · 2025
    Article
  4. mBio · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. FromiScience · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Dense granule protein 3 ofFrontiers in immunology · 2023
    Article
  15. Article
  16. Article
  17. NcPathogens (Basel, Switzerland) · 2022
    Article
  18. Deletion ofBiomedicines · 2022
    Article
  19. Article
  20. Released Parasite-Derived Kinases as Novel Targets for Antiparasitic Therapies.Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Barbara A FoxDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Leah M RommereimDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Rebekah B GuevaraDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Alejandra FallaDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Miryam Andrea Hortua TrianaDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Yanbo SunDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
David J BzikDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA david.j.bzik@dartmouth.edu.
Dartmouth College · US

Funding

IMMUNOBIOLOGY OF MYELOID AND LYMPHOID CELLST32AI007363 · NIAID · DARTMOUTH COLLEGE · PI Claudia V Jakubzick · 1990 to 2026
$9.5M
HOST-MICROBE INTERACTIONST32AI007519 · NIAID · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 1997 to 2026
$5.9M
T GONDII--PYRIMIDINE SYNTHESIS AS A CHEMOTHERAPY TARGETR01AI041930 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 1997 to 2013
$4.2M
Parasite secreted proteins control host response to Toxoplasma gondii infectionR21AI104514 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2013 to 2014
$445k
Regulated virulence and cyst maturation in Toxoplasma gondiiR21AI075931 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2008 to 2009
$440k
Genetic dissection of the Toxoplasma gondii rhoptry kinomeR21AI097018 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2011 to 2012
$435k
Genetic models for post-genome functional analysis of Toxoplasma gondiiR21AI084570 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2009 to 2010
$435k
NIAID NIH HHS R01 AI041930NIAID NIH HHS R21 AI075931NIAID NIH HHS R21 AI084570NIAID NIH HHS R21 AI097018NIAID NIH HHS R21 AI104514NIAID NIH HHS T32 AI007363NIAID NIH HHS T32 AI007519
6 · The paper itself

Abstract

unlabelledIngestion of the obligate intracellular protozoan parasite Toxoplasma gondii causes an acute infection that leads to chronic infection of the host. To facilitate the acute phase of the infection, T. gondii manipulates the host response by secreting rhoptry organelle proteins (ROPs) into host cells during its invasion. A few key ROP proteins with signatures of kinases or pseudokinases (ROPKs) act as virulence factors that enhance parasite survival against host gamma interferon-stimulated innate immunity. However, the roles of these and other ROPK proteins in establishing chronic infection have not been tested. Here, we deleted 26 ROPK gene loci encoding 31 unique ROPK proteins of type II T. gondii and show that numerous ROPK proteins influence the development of chronic infection. Cyst burdens were increased in the Δrop16 knockout strain or moderately reduced in 11 ROPK knockout strains. In contrast, deletion of ROP5, ROP17, ROP18, ROP35, or ROP38/29/19 (ROP38, ROP29, and ROP19) severely reduced cyst burdens. Δrop5 and Δrop18 knockout strains were less resistant to host immunity-related GTPases (IRGs) and exhibited >100-fold-reduced virulence. ROP18 kinase activity and association with the parasitophorous vacuole membrane were necessary for resistance to host IRGs. The Δrop17 strain exhibited a >12-fold defect in virulence; however, virulence was not affected in the Δrop35 or Δrop38/29/19 strain. Resistance to host IRGs was not affected in the Δrop17, Δrop35, or Δrop38/29/19 strain. Collectively, these findings provide the first definitive evidence that the type II T. gondii ROPK proteome functions as virulence factors and facilitates additional mechanisms of host manipulation that are essential for chronic infection and transmission of T. gondii IMPORTANCE: Reactivation of chronic Toxoplasma gondii infection in individuals with weakened immune systems causes severe toxoplasmosis. Existing treatments for toxoplasmosis are complicated by adverse reactions to chemotherapy. Understanding key parasite molecules required for chronic infection provides new insights into potential mechanisms that can interrupt parasite survival or persistence in the host. This study reveals that key secreted rhoptry molecules are used by the parasite to establish chronic infection of the host. Certain rhoptry proteins were found to be critical virulence factors that resist innate immunity, while other rhoptry proteins were found to influence chronic infection without affecting virulence. This study reveals that rhoptry proteins utilize multiple mechanisms of host manipulation to establish chronic infection of the host. Targeted disruption of parasite rhoptry proteins involved in these biological processes opens new avenues to interfere with chronic infection with the goal to either eliminate chronic infection or to prevent recrudescent infections.

Indexed as

AnimalsChronic DiseaseFemaleGene Knockout TechniquesImmunity, InnateMiceMice, Inbred C57BLMice, KnockoutProtein KinasesProtozoan ProteinsToxoplasmaToxoplasmosis, AnimalVirulence FactorsProtein KinasesProtozoan ProteinsVirulence Factors

Identifiers

PMID27165797
PMCPMC4959664
OpenAlexW2389126460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.